DLA intends to issue an unrestricted, fully competitive firm-fixed-price requirements contract for Bicalutamide 50MG Tablets in 30, 100, and 500-count bottles. The contract will have a one-year base term plus four one-year options and establish a national supply source for Department of War, VA, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. The solicitation will be posted on DIBBS and SAM.gov, with a projected solicitation date of October 2026. All sources may submit a proposal.